Bill Kirk

“How much of the business review will be predicated on the outcome of the trial against Kroger? You know, given the damage amounts, I would imagine that the trial outcome could influence funding plans, funding needs, and asset decisions.”

“I think the comment was related specifically to BlackBerry. But maybe more broadly, what is the opportunity for the portfolio in the U.S. or internationally to expand pack size offerings?”

“Jason and Ian, you both mentioned and even quantified the adverse impact of Easter timing in 2Q. What I was wondering, I guess, is at the end of 2Q, did you have a positive July 4th timing benefit?”

“And then if I can on Germany, the market has gotten a little tougher for some on some price compression, but you're showing strong growth there. So can you help us maybe understand your route to market into Germany, and was the unlock for Germany getting bigger for you?”

“Boris, you talked about third-party supply volatility when selling into international markets. So what can your relationship with Canera Biotech do to help remove that volatility, or what other ways can you improve sourcing, and what does international look like if you can remove those sourcing limitations?”